{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:34Z","timestamp":1788322654716,"version":"build-2803163510"},"reference-count":48,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EU 7th framework program, FP7-HEALTH","award":["304927"],"award-info":[{"award-number":["304927"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Persistent infection with human papillomavirus (HPV) can lead to cervical cancer (CxCa). During the progression to CxCa, the expression of HPV oncogenes E6 and E7 is upregulated. In turn, cellular proteins such as p16INK4a are also modulated. The combined detection of HPV oncogenes and cellular biomarkers indicative for dysplasia could be informative and convey better specificity than the current HPV tests that cannot discriminate transient infection from dysplastic changes. Methods: The QuantiGeneTM 2.0 Plex Assay platform was chosen for the effective multiplexing and quantitative detection of seven HPV-E7 mRNA targets (HPV6, 16, 18, 31, 45, 59, and 68) and the cellular mRNA of p16INK4a as a biomarker for HPV-induced transformation. Actin-beta (ACTB) and hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1) were included as reference markers. Sequences for the specific capture and detector probes were customized and developed by ThermoFisher and formulated as a QuantiGene proof-of-concept (QG-POC) plex-set. The crude lysates of the HPV-positive cervical cancer cell lines CaSki (HPV16), HeLa (HPV18), MRHI-215 (HPV45), Erin59 (HPV59), ME180 (HPV68), and the HPV-negative cell line C33A, as well as liquid-based cytology smear samples (n = 441) were analyzed. The study was a proof-of-concept evaluating the feasibility of the platform. Logistic regression and receiver operating characteristic (ROC) analyses were performed to test for the sensitivity and specificity of HPV detection and dysplastic stage discrimination. Results: A QG-POC assay specifically and sensitively detects the HPV-E7 mRNA of seven different genotypes with an assay linearity between 20 and 13,000 cells. Cellular mRNA was detected from the crude lysates of cell lines and of cellular material from clinical liquid-based cytology smear samples. By combining HPV-E7 and p16INK4a expression normalized to ACTB, high-grade dysplasia (HCIN) and invasive cervical cancer (CxCa) were detectable, discriminable, and correlated to the biomarker expression strength. The ROC analysis from the multivariate logistic regression model including HPV-E7 and p16 INK4a resulted in an AUC of 0.74, at the optimal cut-off (sensitivity: 70.4%; specificity: 66.0%) for HCIN detection. CxCa was detected with an AUC of 0.77 (sensitivity: 81.8%, specificity: 77.4%). Conclusions: The QG-POC assay is sufficiently sensitive to detect and quantify HPV-E7 and cellular mRNA species. Multiplexing allows the specific detection of at least 10 analytes in a single reaction. Determining the abundance of E7 and p16INK4a transcripts when normalized to ACTB is informative about the presence of cervical dysplasia and potentially discriminates between low-grade and high-grade dysplasia and invasive cervical cancer. Further studies including more HPV genotypes and biomarkers are warranted.<\/jats:p>","DOI":"10.3390\/diagnostics13061135","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T02:29:59Z","timestamp":1679020199000},"page":"1135","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Human Papillomavirus E7 and p16INK4a mRNA Multiplexed Quantification by a QuantiGeneTM Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-1572","authenticated-orcid":false,"given":"Anna Sophie","family":"Skof","sequence":"first","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Rotenberg","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Viktor Felix","family":"Hannemann","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thies","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Boschetti-Gr\u00fctzmacher","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-3009","authenticated-orcid":false,"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Gynecology, CVK, HPV Research Laboratory, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Augustenburgerplatz 1, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer. J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0020-7292(07)60004-6","article-title":"The epidemiology of human papillomavirusinfection and its association with cervical cancer","volume":"94","author":"Bosch","year":"2006","journal-title":"Int. J. Gynecol. Obs."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"Fauquet","year":"2004","journal-title":"Virology"},{"key":"ref_4","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). A Review of Human Carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum., 100, 1\u2013441."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-2458-12-992","article-title":"Reduced cervical cancer incidence and mortality in Canada: National data from 1932 to 2006","volume":"12","author":"Dickinson","year":"2012","journal-title":"BMC Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00404-017-4324-x","article-title":"Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: Preliminary results of the PIPAVIR study","volume":"295","author":"Chatzistamatiou","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GCO.0b013e32835c5d10","article-title":"Primary human papillomavirus testing in organized cervical screening","volume":"25","author":"Dillner","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdu217","article-title":"Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: A position paper by the European Society for Medical Oncology (ESMO)","volume":"25","author":"Ciardiello","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mcp.2011.05.003","article-title":"The HPV16 transcriptome in cervical lesions of different grades","volume":"25","author":"Schmitt","year":"2011","journal-title":"Mol. Cell Probes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1525-1438.2006.00355.x","article-title":"Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia","volume":"16","author":"Ishikawa","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP Complex Functions as a Ubiquitin-Protein Ligase in the Ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"key":"ref_17","first-page":"4620","article-title":"E7 Protein of Human Papilloma Virus-16 Induces Degradation of Retinoblastoma Protein through the Ubiquitin-Proteasome Pathway","volume":"56","author":"Boyer","year":"1996","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"488.E1","DOI":"10.1016\/j.ajog.2009.05.046","article-title":"Value of p16(INK4a) as a marker of progression\/regression in cervical intraepithelial neoplasia grade 1","volume":"201","author":"Garcia","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2006.02.013","article-title":"A multiplex branched DNA assay for parallel quantitative gene expression profiling","volume":"352","author":"Flagella","year":"2006","journal-title":"Anal. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cccn.2005.06.023","article-title":"Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection","volume":"363","author":"Dunbar","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0042-6822(03)00492-6","article-title":"Human papillomavirus type 59 immortalized keratinocytes express late viral proteins and infectious virus after calcium stimulation","volume":"314","author":"Lehr","year":"2003","journal-title":"Virology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.30761","article-title":"Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study","volume":"141","author":"Agorastos","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/CIN.S963","article-title":"Semantic Integration of Cervical Cancer Data Repositories to Facilitate Multicenter Association Studies: The ASSIST Approach","volume":"8","author":"Agorastos","year":"2009","journal-title":"Cancer Inform."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.44.2.504-512.2006","article-title":"Bead-based multiplex genotyping of human papillomaviruses","volume":"44","author":"Schmitt","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/JCM.02227-07","article-title":"Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers","volume":"46","author":"Schmitt","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","unstructured":"R Core Team (2017). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_29","unstructured":"Wickham, H., Fran\u00e7ois, R., Henry, L., and M\u00fcller, K. (2020). dplyr: A Grammar of Data Manipulation, Posit, PBC."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis, Springer.","DOI":"10.1007\/978-3-319-24277-4"},{"key":"ref_31","first-page":"155","article-title":"A Power Primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Quant. Methods Psychol."},{"key":"ref_32","unstructured":"Nakazawa, M. (2019). fmsb: Functions for Medical Statistics Book with some Demographic Data, R Foundation for Statistical Computing."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The Measurement of Observer Agreement for Categorical Data","volume":"33","author":"Landis","year":"2012","journal-title":"Biometrics"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., and M\u00fcller, M. (2011). pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-77"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: Visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinformatics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/cncr.10439","article-title":"Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis","volume":"94","author":"Lu","year":"2002","journal-title":"Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.3970","article-title":"One virus, one lesion--individual components of CIN lesions contain a specific HPV type","volume":"227","author":"Quint","year":"2012","journal-title":"J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2018.10.008","article-title":"Bead-based RNA multiplex panels for biomarker detection in oncology samples","volume":"158","author":"Scerri","year":"2018","journal-title":"Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/jcm.34.3.738-744.1996","article-title":"Two Novel Genital Human Papillomavirus (HPV) Types, HPV68 and HPV70, Related to the Potentially Oncogenic HPV39","volume":"34","author":"Longuet","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Jaworek, H., Kubanova, K., Koudelakova, V., Slavkovsky, R., Drabek, J., and Hajduch, M. (2019). Pitfalls of commercially available HPV tests in HPV68a detection. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220373"},{"key":"ref_42","first-page":"6132","article-title":"Detection of High-Risk Cervical Intraepithelial Neoplasia and Cervical Cancer by Amplification of Transcripts Derived from Integrated Papillomavirus Oncogenes1","volume":"59","author":"Klaes","year":"1999","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/modpathol.2011.179","article-title":"p16INK(4)a and p14ARF mRNA expression in Pap smears is age-related","volume":"25","author":"Kuhn","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","article-title":"Gene expression profiles of primary HPV16- and HPV18-infected early-stage cervical cancers and normal cervical epithelium: Identification of novel candidate molecular markers for cervical cancer diagnosis and therapy","volume":"331","author":"Santin","year":"2005","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/0100-69912017002005","article-title":"Evaluation of Telomerase (hTert), Ki67 and p16ink4a expressions in low and high-grade cervical intraepithelial lesions","volume":"44","author":"Goulart","year":"2017","journal-title":"Rev. Col. Bras. Cir."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: The Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dorji, N., Tshering, S., Choden, S., Chhetri, M., Bhujel, D., Wangden, T., Pradhan, B., Bhutia, P.C., and Tshomo, U. (2022). Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+). BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10030-7"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/6\/1135\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:56:47Z","timestamp":1760122607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/6\/1135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["diagnostics13061135"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13061135","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}